In addition, the abundance of FSHR in patients with primary renal carcinoma was nearly comparable to that in testicular cancer, in which the surge was different from the physiologically low FSHR expression in the kidneys (Fagerberg et al., 2014). The gene discussed is FSHR; the disease is testicular cancer.